Operative and conservative treatment of tubo-ovarian abscess due to pelvic inflammatory disease

Observational OA: closed CC0 ⤵ 3 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-13 ⓘ

This retrospective study compared operative and conservative treatment for 83 tubo-ovarian abscess patients, finding conservative therapy with antibiotics and surgery when applicable effective for unruptured cases.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Of 83 patients with tubo-ovarian abscess studied retrospectively, 18 were treated within 24 hours of admission with total abdominal hysterectomy and bilateral salpingoo-ophorectomy. The other 65 patients were treated conservatively. In six patients, conservative therapy proved an immediate failure, and 14 patients had delayed failure. Thirty-nine patients were successfully treated conservatively, and six were lost to follow-up. We examined the length of hospital stay in the surgically treated group and the conservatively treated group. Immediate operation and delayed operation were examined in terms of mortality, morbidity, and hospital stay. Conservative therapy consisting of broad spectrum antibiotics combined with conservative operation when applicable is an effective method of treating unruptured tubo-ovarian abscess.

My notes (saved in your browser only)

MeSH descriptors

Abscess Fallopian Tube Diseases Ovarian Diseases Pelvic Inflammatory Disease Abscess Abscess Abscess Adolescent Adult Anti-Bacterial Agents Anti-Bacterial Agents Castration Combined Modality Therapy Fallopian Tube Diseases Fallopian Tube Diseases Fallopian Tube Diseases Female Humans Hysterectomy Middle Aged

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (3)

Cited by (3)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:58:26.348914+00:00
License: CC0 · commercial use OK